Kurt Christensen

Assistant Professor of Population Medicine at the Harvard Pilgrim Health Care Institute

[Kurt Christensen @kdchrist]

Now in press: acceptance of recommendations from PGx clinical decision support for clopidogrel increased from 24% in 2015 to 63% in 2023. Wow. Great work by #pharmacogenomics at @SanfordHealth! https://t.co/7AWvARyxSj

[Kurt Christensen @kdchrist]

Big step. Medicare hadn't been able to negotiate drug prices despite the vast needs of seniors. The US wildly outspends most countries on health (and gets less. https://t.co/Z2KHYP4D2p). As others' have stated more elegantly, "it's the prices, ___" (https://t.co/IBumIFYrgV)

[Kyle LaHucik @ky_lahucik]

The first 10 drug price negotiations under the IRA are here:

https://t.co/KSzLMzhkzt

[Kurt Christensen @kdchrist]

Haven't had a chance thank my co-authors for this important paper, led by @Marshall_HEcon, from the @GEECSEcon group!

[Economics & genomics @econ_genomics]

[1] Paving the path for implementation of clinical genomic sequencing globally - Are we ready? | @Marshall_HEcon @jbuchanan_ox @kdchrist @GeertFrederix @IliasGoranitis @maartenijzerman @JeroenPJansen @tara_lavelle @KathrynP_phd | https://t.co/QeBdgaxRQM [2/3] #healtheconomics

[Kurt Christensen @kdchrist]

"Evaluating the utility of multi-gene, multidisease
population-based panel testing
accounting for uncertainty in penetrance
estimates", now in press at #NPJgenomicMedicine at https://t.co/Wb7afiU6Uw. Kudos to Jane Liang for leading this important work (complete with RShiny app!)

[Kurt Christensen @kdchrist]

Huge congratulations to @AdelsonSophia for leading these analyses about familial communication and cascade testing data following genetic testing offered as an elective clinical service at @SanfordHealth.

[Genomes2People @Genomes2People]

🌟 Exciting News! 🌟We are thrilled to congratulate our colleague, @AdelsonSophia, on successfully leading the publication of her first, first-author manuscript, "Familial Communication and Cascade Testing Following Elective Genomic Testing"!

Read Here: https://t.co/QHCuMKcOtm

[Genomes2People @Genomes2People]

🌟 Exciting News! 🌟We are thrilled to congratulate our colleague, @AdelsonSophia, on successfully leading the publication of her first, first-author manuscript, "Familial Communication and Cascade Testing Following Elective Genomic Testing"!

Read Here: https://t.co/QHCuMKcOtm

[Kurt Christensen @kdchrist]

Hello academia. Isdin Oke, is hiring a research assistant. Dr. Oke’s research is in the area of ophthalmology with a strong focus on disparities and access to care. Candidates should experience with R and health services research methods. Learn more at https://t.co/9YF1MxMDmS.

[Hadley Stevens Smith @hadleyssmith]

I am hiring a postdoc to work on health econ topics related to Neurofibromatosis type 1 (NF1), a genetic tumor predisposition syndrome. 🧬 Work with a collaborative team of outcomes researchers and clinicians at @CHeRP_DPM & Harvard hospitals. Apply here: https://t.co/upc9XJBnSz

[Kurt Christensen @kdchrist]

With @hadleyssmith at her #PreEMPT Model poster @TheACMG Annual meeting. Catch Hadley at poster P858 10:30-12:00 Friday about provider and patient attitudes toward genome sequencing #babyseq @PROMoTeR_DPM

[Kurt Christensen @kdchrist]

Our comparison of the medical impact of preemptive and reactive PGx testing to inform antiplatelet therapy is now in press at @ejhg_journal! https://t.co/rTgadPXETa @SanfordHealth @PROMoTeR_DPM

[Kurt Christensen @kdchrist]

Is genetic screening for "CDC Tier 1" conditions cost effective? Read for yourself at https://t.co/jvILTjK7vU. Rigorous work from a good group.

[Hadley Stevens Smith @hadleyssmith]

How frequently do relatives of patients with positive #exome sequencing results complete cascade testing? Using data from two US labs, we found that fewer than 8% of probands had at least one relative tested. Terrific work led by Julie @bcmgcprogram https://t.co/Y6yIVbJ6lH

[Hadley Stevens Smith @hadleyssmith]

Very happy to share this research that explores how caregivers of pediatric patients with suspected genetic conditions approach decision-making about genomic sequencing, with a specific focus on family-level considerations. Read the full article here: https://t.co/NW9qFSUzwU

[Kurt Christensen @kdchrist]

Now in press: awareness about, use of, & perceived utility of genetic testing among over 5,500 Hispanic Community Health Study / Study of Latinos participants https://t.co/Mb7oNs8auj. Thank you to HCHS/SOL investigators and participants! https://t.co/a0PGSNbXDE #genetictesting

[Kurt Christensen @kdchrist]

For you job seekers, Stacey has a rare combination of qualitative and quantitative expertise. She's a wonderful colleague, too!

[Kurt Christensen @kdchrist]

Check it out! https://t.co/cvQFG9fpw7

[Robert C. Green @RobertCGreen]

Just out this morning in AJHG, the most detailed description ever published for returning genomic results in research from our @MassGenBrigham #Biobank! Congrats to the first/last authors @CarrieBlout @NidhiPShahMD, Kalotina Machini & Matt Lebo.

[Dr. Jason Vassy @jasonvassy]

#ImpSci in action as we bring PGx testing to Vets

[Kurt Christensen @kdchrist]

Now in press: https://t.co/UXhUChXCuJ Nice job, Julia Wynn and @HilaMilo. Interesting to re-read, "The most common reasons indicated for not sharing were that the family members were too young (38%)" just after our cascade testing paper was published https://t.co/3hPwLOWOtR

[Ann Wu MD MPH @DrAnnGenesprout]

Our study published today suggests that cascade genetic testing of siblings would reduce cancer deaths by over 50%. Still much work needs to be done in this area.

[Dr. Jason Vassy @jasonvassy]

I'm very much looking forward to some thoughtful discussion...and need to get cracking on making my slides!